Lee Ainslie - Maverick Capital Ltd
Holding/activity history for IDEXX Laboratories (IDXX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2024 Q1 | 0 | 0.00 | Sell 100.00% | 0.02 | SEC | ||
| 2023 Q4 | 1,481 | 0.02 | Buy | 0.02 | $555.05 | $822,029 | SEC |
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2023 Q2 | 809 | 0.01 | Buy | 0.01 | $502.23 | $406,304 | SEC |
| 2022 Q4 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2022 Q3 | 1,492 | 0.01 | Buy | 0.01 | $325.74 | $486,000 | SEC |
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | 0.01 | SEC | ||
| 2021 Q2 | 1,691 | 0.01 | Add 4,470.27% | <0.01 | $631.58 | $1,068,000 | SEC |
| 2021 Q1 | 37 | <0.01 | Reduce 66.96% | <0.01 | $486.49 | $18,000 | SEC |
| 2020 Q4 | 112 | <0.01 | Reduce 95.69% | 0.02 | $500.00 | $56,000 | SEC |
| 2020 Q3 | 2,596 | 0.02 | Reduce 35.45% | 0.01 | $393.30 | $1,021,000 | SEC |
| 2020 Q2 | 4,022 | 0.03 | Reduce 59.84% | 0.03 | $330.18 | $1,328,000 | SEC |
| 2020 Q1 | 10,015 | 0.05 | Add 15.27% | <0.01 | $242.24 | $2,426,000 | SEC |
| 2019 Q4 | 8,688 | 0.03 | Buy | 0.03 | $261.16 | $2,269,000 | SEC |
| 2017 Q4 | 0 | 0.00 | Sell 100.00% | 0.07 | SEC | ||
| 2017 Q3 | 32,420 | 0.07 | Add 37.49% | 0.02 | $155.49 | $5,041,000 | SEC |
| 2017 Q2 | 23,580 | 0.05 | Buy | 0.05 | $161.41 | $3,806,000 | SEC |